When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EBS - Emergent Bio's chikungunya vaccine shows positive action in mid-stage study
Emergent Biosolutions Inc.
Preliminary data from a Phase 2 clinical trial evaluating Emergent BioSolutions' (NYSE:EBS) Fast Track-tagged CHIKV-VLP, its chikungunya virus-like particle vaccine candidate, showed a positive effect. Seroconversion occurred in 74 - 98% of participants by day 7 after a single dose and in 100% of participants by day 28 after a second dose. Immune responses were sustained through the six-month visit.
More news on: Emergent BioSolutions Inc., Healthcare stocks news,